In this randomized control trial of neuromyelitis optica spectrum disorder (NMOSD) patients with aquaporin-4 antibodies (AQP4-IgG), those randomized to receive the eculizumab complement inhibitor experienced a lower relapse rate over... | SnapWidget

In this randomized control trial of neuromyelitis optica spectrum disorder (NMOSD) patients with aquaporin-4 antibodies (AQP4-IgG), those randomized to receive the eculizumab complement inhibitor experienced a lower relapse rate over 24 months than placeb

by 2minmed 5 years ago | via Instagram

Love this little animal lover more than I ever could imagine ???? #dagensoutfit #ootd #lookoftheday #momstyle #momlife #boho #longhair #nordmaling #umeå #instagood #baby #babygirl #momlove #motherhood #kids #momanddaughter #beachbag #kidsfashion #babyfash

by annawii 7 years ago | via Instagram

I looooove the new vegan box from @thehealthybox - the vanilla sparkling water is ???????????????????????? #thehealthybox #healthybox #ramlösa #yummie #friggs #vegan #instagood #umeå #nordmaling

by annawii 7 years ago | via Instagram

Todays mom and mini ???? #dagensoutfit #ootd #lookoftheday #momstyle #momlife #boho #longhair #nordmaling #umeå #instagood #babygirl #kidsfashion #momanddaughter #bohochic #polarnopyret

by annawii 7 years ago | via Instagram